imipenem monohydrate + cilastatin sodium Powder for solution for infusion 500 mg + 500 mg - 25 ml

This pharmaceutical company has over 20 years of experience serving domestic and international markets in diverse regions like the EU and North America. They specialize in manufacturing a wide range of pharmaceutical products, including prescription medications, likely encompassing key therapy areas such as nephrology, cardiology, oncology, and pediatrics. Their product portfolio includes various dosage forms and boasts GMP certifications. They actively engage in research and development, evidenced by mentions of new drug launches like "Urapidil" for hypertension and "Bivalirudin" used in COVID-19 patients with ECMO. While they do not engage in online sales, the company emphasizes its commitment to quality and high-tech production facilities.